Gastrointestinal tract symptoms from intravenously administered erythromycin.
D000328:Adult; D004917:Erythromycin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D011019:Pneumonia, Mycoplasma / Q000188:drug therapy; D014839:Vomiting / Q000139:chemically induced*
C010948:erythromycin lactobionate; D004917:Erythromycin